{
    "organizations": [],
    "uuid": "8b96de4ab3cc7da3712106e7e65f16ad16211949",
    "author": "",
    "url": "https://www.reuters.com/article/brief-mallinckrodt-completes-stannsoporf/brief-mallinckrodt-completes-stannsoporfin-new-drug-application-filing-idUSFWN1OZ0YJ",
    "ord_in_thread": 0,
    "title": "BRIEF-Mallinckrodt Completes Stannsoporfin New Drug Application Filing",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "January 4, 2018 / 9:53 PM / in 9 minutes BRIEF-Mallinckrodt Completes Stannsoporfin New Drug Application Filing Reuters Staff \nJan 4 (Reuters) - Mallinckrodt Plc: \n* MALLINCKRODT COMPLETES STANNSOPORFIN NEW DRUG APPLICATION FILING Source text for Eikon: Further company coverage:",
    "published": "2018-01-04T23:52:00.000+02:00",
    "crawled": "2018-01-05T00:13:16.007+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "january",
        "pm",
        "minute",
        "completes",
        "stannsoporfin",
        "new",
        "drug",
        "application",
        "filing",
        "reuters",
        "staff",
        "jan",
        "reuters",
        "mallinckrodt",
        "plc",
        "mallinckrodt",
        "completes",
        "stannsoporfin",
        "new",
        "drug",
        "application",
        "filing",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}